Principal Investigators (PI’s)
The applicants are established experts in the fields of drug delivery, blood-brain barrier function, receptor-mediated transport, or neurovascular regulation
Department of Neuroscience, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen N
Martin Lauritzen is an MD who works with neurological patients and clinical studies of the brain in sepsis and cognitive decline. His translational works concerns brain activity, blood flow and energy use and the blood-brain barrier. Martin is founding member of the steering committee for COSBID, a large multi-center study of patients with acutely injured brain tissue (www.cosbid.org). Martin is currently also one of the team leaders of the Centre for Healthy Aging, and now the Director of RIBBDD.
Thomas Lars Andresen
Department of Micro- and Nanotechnology, Produktionstorvet, Building 423, 2800 Kgs. Lyngby
Thomas Andresen is an expert in design and engineering of advanced drug delivery systems for site-specific targeting of therapeutic agents and controlled drug release in normal and diseased tissue. Thomas is the founder and leader of the DTU Centre of Nanomedicine, which is a research network that currently includes researchers from four DTU departments. He is furthermore heading strategic research in Biomedical Nanotechnology and Life Sciences.
Morten Schallburg Nielsen
Department of Biomedicine, Aarhus University, Ole Worms Allé, 8000 Aarhus C
Morten Schallburg Nielsen is an expert in molecular and cell biology studies of cellular transport. Morten is group leader in the MIND centre and in the newly established interdisciplinary centre MEMBRANES at Aarhus University.
Laboratory of Neurobiology, Department of Health Science and Technology, Aalborg University, Fredrik Bajers Vej 3, 9220 Aalborg Ø
Torben Moos is an expert in studies of physiological and pathological BBB models in vivo. Torben heads the neurobiology group at Department of Medicine and Health Technology, Aalborg University (AAU) and is the founder and leader of a center for development of targeted therapeutics in treatment of glioblastoma multiforme at AAU.
Faculty of Health Sciences, Department of Pharmacy, Universitetsparken 2, 2100 Copenhagen Ø
Birger Brodin is heading the research group "Drug Transporters in ADME" at the Department of Pharmacy, the Faculty of Health Sciences.
Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø
Kristian Strømgaard is Professor in Chemical Biology and Director of Center for Biopharmaceuticals. The overall focus of the Strømgaard Lab is studies of protein-protein interactions with putative therapeutic relevance. The research combines tools from chemistry and biology to provide molecular-level insight into the functions and mechanisms, and to develop peptide-based inhibitors of these interactions.
PhD defence: Charlotte Goldeman Andersen
Jul 02, 2019
Charlotte Goldeman Andersen will defend her PhD theisis...
RIBBDD biannual meeting, April 2019
May 10, 2019
On April 23-24, almost 50 members from the RIBBDD network met at Helnan Marselis Hotel in Aarhus...
RIBBDD biannual meeting, November 2018
Dec 03, 2018
On November 28-29th, 48 researchers from the RIBBDD network gathered at University...
Welcome to WP6
Sep 27, 2018
RIBBDD has the pleasure of welcoming professor Kristian Strømgaard and his group...
Sep 26, 2018
The RIBBDD network just received the wonderful news that...